Aim: The aim of this paper is to study the safety and efficacy (measured by therapeutic level) of once daily gentamicin in neonates >or=32 weeks of gestation and
Setting: Level II neonatal intensive care unit.
Subjects: Neonates >or=32 weeks of gestation and